These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37439857)

  • 1. Association between urinary C-megalin levels and progressive kidney dysfunction: a cohort study based on the diabetes distress and care registry at Tenri (DDCRT 24).
    Niihata K; Nishiwaki H; Kinoshita M; Kurosawa K; Sakuramachi Y; Matsunaga S; Okamura S; Tsujii S; Hayashino Y; Kurita N;
    Acta Diabetol; 2023 Dec; 60(12):1643-1650. PubMed ID: 37439857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of urinary C-megalin with albuminuria and renal function in diabetes: a cross-sectional study (Diabetes Distress and Care Registry at Tenri [DDCRT 21]).
    Kurita N; Kinoshita M; Fujimura M; Kurosawa K; Sakuramachi Y; Takano K; Okamura S; Kitatani M; Tsujii S; Norton EC; Hayashino Y;
    J Nephrol; 2022 Jan; 35(1):201-210. PubMed ID: 33646560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary C-megalin as a novel biomarker of progression to microalbuminuria: A cohort study based on the diabetes Distress and Care Registry at Tenri (DDCRT 22).
    Nishiwaki H; Niihata K; Kinoshita M; Fujimura M; Kurosawa K; Sakuramachi Y; Takano K; Matsunaga S; Okamura S; Kitatani M; Tsujii S; Hayashino Y; Kurita N;
    Diabetes Res Clin Pract; 2022 Apr; 186():109810. PubMed ID: 35247529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between dipstick hematuria and decline in estimated glomerular filtration rate among Japanese patients with type 2 diabetes: A prospective cohort study [Diabetes Distress and Care Registry at Tenri (DDCRT 14)].
    Mashitani T; Hayashino Y; Okamura S; Kitatani M; Furuya M; Iburi T; Tsujii S; Ishii H;
    J Diabetes Complications; 2017 Jul; 31(7):1079-1084. PubMed ID: 28499960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of serum uric acid levels with the risk of development or progression of albuminuria among Japanese patients with type 2 diabetes: a prospective cohort study [Diabetes Distress and Care Registry at Tenri (DDCRT 10)].
    Hayashino Y; Okamura S; Tsujii S; Ishii H
    Acta Diabetol; 2016 Aug; 53(4):599-607. PubMed ID: 26935413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of urinary tubule injury markers for predicting progression of renal dysfunction in patients with type 2 diabetes and albuminuria: The Fukuoka Diabetes Registry.
    Ide H; Iwase M; Ohkuma T; Fujii H; Komorita Y; Oku Y; Higashi T; Yoshinari M; Nakamura U; Kitazono T
    Diabetes Res Clin Pract; 2022 Apr; 186():109840. PubMed ID: 35331809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary A- and C-megalin predict progression of diabetic kidney disease: an exploratory retrospective cohort study.
    Iida T; Hosojima M; Kabasawa H; Yamamoto-Kabasawa K; Goto S; Tanaka T; Kitamura N; Nakada M; Itoh S; Ogasawara S; Kaseda R; Suzuki Y; Narita I; Saito A
    J Diabetes Complications; 2022 Nov; 36(11):108312. PubMed ID: 36228564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of urinary full-length and ectodomain forms of megalin in patients with type 2 diabetes.
    Ogasawara S; Hosojima M; Kaseda R; Kabasawa H; Yamamoto-Kabasawa K; Kurosawa H; Sato H; Iino N; Takeda T; Suzuki Y; Narita I; Yamagata K; Tomino Y; Gejyo F; Hirayama Y; Sekine S; Saito A
    Diabetes Care; 2012 May; 35(5):1112-8. PubMed ID: 22410816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of prechemotherapy urinary megalin ectodomain (A-megalin) levels with the development of cisplatin-induced nephrotoxicity: a prospective observational study.
    Shoji S; Hosojima M; Kabasawa H; Kondo R; Miura S; Watanabe S; Aoki N; Kaseda R; Kuwahara S; Tanabe N; Hirayama Y; Narita I; Kikuchi T; Kagamu H; Saito A
    BMC Cancer; 2019 Dec; 19(1):1170. PubMed ID: 31791266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney Function as Risk Factor and Predictor of Cardiovascular Outcomes and Mortality Among Older Adults.
    Kühn A; van der Giet M; Kuhlmann MK; Martus P; Mielke N; Ebert N; Schaeffner ES
    Am J Kidney Dis; 2021 Mar; 77(3):386-396.e1. PubMed ID: 33197533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Baseline Levels of Tumor Necrosis Factor Receptor 1 Are Associated With Progression of Kidney Disease in Indigenous Australians With Diabetes: The eGFR Follow-up Study.
    Barr ELM; Barzi F; Hughes JT; Jerums G; Hoy WE; O'Dea K; Jones GRD; Lawton PD; Brown ADH; Thomas M; Ekinci EI; Sinha A; Cass A; MacIsaac RJ; Maple-Brown LJ
    Diabetes Care; 2018 Apr; 41(4):739-747. PubMed ID: 29367427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of proton pump inhibitor use with the risk of the development or progression of albuminuria among Japanese patients with diabetes: A prospective cohort study [Diabetes Distress and Care Registry at Tenri (DDCRT 16)].
    Hayashino Y; Okamura S; Mashitani T; Tsujii S; Ishii H;
    Diabetes Res Clin Pract; 2018 Apr; 138():1-7. PubMed ID: 29382588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stronger Association of Albuminuria with the Risk of Vascular Complications than Estimated Glomerular Filtration Rate in Type 2 Diabetes.
    Hong X; Huang L; Zhang Y; Shen X; Weng S; Zeng F; Zhao F; Yan S
    Kidney Blood Press Res; 2021; 46(5):550-562. PubMed ID: 34428770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary megalin in association with progression factors of diabetic nephropathy.
    Akour A; Kasabri V; Bulatova N; Al-Motassem Y; Fahmawi H; Momani M; Zayed A; Alquoqa R; AlHawari H
    Bratisl Lek Listy; 2019; 120(7):532-535. PubMed ID: 31602990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kidney function measures and cardiovascular outcomes in people with diabetes: the Hoorn Diabetes Care System cohort.
    Dal Canto E; Elders PJM; van der Heijden AA; van Ballegooijen AJ; Lissenberg-Witte BI; Rutters F; Beulens JWJ
    Diabetologia; 2023 Mar; 66(3):482-494. PubMed ID: 36347992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with type 2 diabetes having higher glomerular filtration rate showed rapid renal function decline followed by impaired glomerular filtration rate: Japan Diabetes Complications Study.
    Moriya T; Tanaka S; Sone H; Ishibashi S; Matsunaga S; Ohashi Y; Akanuma Y; Haneda M; Katayama S
    J Diabetes Complications; 2017 Feb; 31(2):473-478. PubMed ID: 27396240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Atrasentan on Kidney and Heart Failure Outcomes by Baseline Albuminuria and Kidney Function: A
    Waijer SW; Gansevoort RT; Bakris GL; Correa-Rotter R; Hou FF; Kohan DE; Kitzman DW; Makino H; McMurray JJV; Perkovic V; Tobe S; Parving HH; de Zeeuw D; Heerspink HJL
    Clin J Am Soc Nephrol; 2021 Dec; 16(12):1824-1832. PubMed ID: 34853062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in urinary albumin as a surrogate for kidney disease progression in people with type 2 diabetes.
    Yokoyama Y; Hanai K; Mori T; Yamamoto Y; Yoshida N; Murata H; Shinozaki T; Babazono T
    Clin Exp Nephrol; 2023 May; 27(5):465-472. PubMed ID: 36840900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment and validation of the cut-off values of estimated glomerular filtration rate and urinary albumin-to-creatinine ratio for diabetic kidney disease: A multi-center, prospective cohort study.
    Gao Z; Zhu Y; Sun X; Zhu H; Jiang W; Sun M; Wang J; Liu L; Zheng H; Qin Y; Zhang S; Yang Y; Xu J; Yang J; Shan C; Chang B
    Front Endocrinol (Lausanne); 2022; 13():1064665. PubMed ID: 36578951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined changes in albuminuria and kidney function and subsequent risk for kidney failure in type 2 diabetes.
    Oshima M; Toyama T; Hara A; Shimizu M; Kitajima S; Iwata Y; Sakai N; Furuichi K; Haneda M; Babazono T; Yokoyama H; Iseki K; Araki SI; Ninomiya T; Hara S; Suzuki Y; Iwano M; Kusano E; Moriya T; Satoh H; Nakamura H; Makino H; Wada T
    BMJ Open Diabetes Res Care; 2021 Jun; 9(1):. PubMed ID: 34193460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.